1. Fitzpatrick TB, Breathnach AS. The epidermal melanin unit system. Dermatol Wochenschr. 1963; 147:481–489.
2. Yamaguchi Y, Hearing VJ. Physiological factors that regulate skin pigmentation. Biofactors. 2009; 35:193–199.
Article
3. Staricco RJ, Pinkus H. Quantitative and qualitative data on the pigment cells of adult human epidermis. J Invest Dermatol. 1957; 28:33–45.
Article
4. Alaluf S, Barrett K, Blount M, Carter N. Ethnic variation in tyrosinase and TYRP1 expression in photoexposed and photoprotected human skin. Pigment Cell Res. 2003; 16:35–42.
Article
5. Alaluf S, Atkins D, Barrett K, Blount M, Carter N, Heath A. Ethnic variation in melanin content and composition in photoexposed and photoprotected human skin. Pigment Cell Res. 2002; 15:112–118.
Article
6. Rawlings AV. Ethnic skin types: are there differences in skin structure and function? Int J Cosmet Sci. 2006; 28:79–93.
Article
7. Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ito S, Pipitone MA, Abdel-Malek ZA. Cutaneous photobiology. The melanocyte vs the sun: who will win the final round? Pigment Cell Res. 2003; 16:434–447.
Article
8. Smith SS, Jordan WD. An essay on the causes of the variety of complexion and figure in the human species. Cambridge: Belknap Press of Harvard University Press;1965.
9. Mitchell J, Collinson P. An essay upon the causes of the different colours of people in different climates. Phil Trans. 1744; 43:102–150.
10. Jablonski NG, Chaplin G. The evolution of human skin coloration. J Hum Evol. 2000; 39:57–106.
Article
11. Sturm RA. Molecular genetics of human pigmentation diversity. Hum Mol Genet. 2009; 18:R9–R17.
Article
12. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet. 2007; 39:1443–1452.
Article
13. Han J, Kraft P, Nan H, Guo Q, Chen C, Qureshi A, et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 2008; 4:e1000074.
Article
14. Rees JL. The melanocortin 1 receptor (MC1R): more than just red hair. Pigment Cell Res. 2000; 13:135–140.
Article
15. Böhm M, Luger TA, Tobin DJ, García-Borrón JC. Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol. 2006; 126:1966–1975.
Article
16. Smith R, Healy E, Siddiqui S, Flanagan N, Steijlen PM, Rosdahl I, et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol. 1998; 111:119–122.
Article
17. John PR, Makova K, Li WH, Jenkins T, Ramsay M. DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals. Ann N Y Acad Sci. 2003; 994:299–306.
Article
18. Cui R, Widlund HR, Feige E, Lin JY, Wilensky DL, Igras VE, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell. 2007; 128:853–864.
Article
19. Tada A, Suzuki I, Im S, Davis MB, Cornelius J, Babcock G, et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ. 1998; 9:575–584.
20. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res. 2004; 17:96–110.
Article
21. Murase D, Hachiya A, Amano Y, Ohuchi A, Kitahara T, Takema Y. The essential role of p53 in hyperpigmentation of the skin via regulation of paracrine melanogenic cytokine receptor signaling. J Biol Chem. 2009; 284:4343–4353.
Article
22. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 1992; 5:357–361.
Article
23. Kovacs D, Flori E, Maresca V, Ottaviani M, Aspite N, Dell'Anna ML, et al. The eumelanin intermediate 5,6-dihydroxyindole-2-carboxylic acid is a messenger in the cross-talk among epidermal cells. J Invest Dermatol. 2012; 132:1196–1205.
Article
24. Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, et al. A -defensin mutation causes black coat color in domestic dogs. Science. 2007; 318:1418–1423.
Article
25. Swope VB, Jameson JA, McFarland KL, Supp DM, Miller WE, McGraw DW, et al. Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3. J Invest Dermatol. 2012; 132:2255–2262.
Article
26. Jarrett SG, Wolf Horrell EM, Boulanger MC, D'Orazio JA. Defining the contribution of MC1R physiological ligands to ATR phosphorylation at Ser435, a predictor of DNA repair in melanocytes. J Invest Dermatol. 2015; 135:3086–3095.
Article
27. Hedley S, Gawkrodger DJ, Weetman AP, MacNeil S. Investigation of the influence of extracellular matrix proteins on normal human melanocyte morphology and melanogenic activity. Br J Dermatol. 1996; 135:888–897.
Article
28. Hara M, Yaar M, Tang A, Eller MS, Reenstra W, Gilchrest BA. Role of integrins in melanocyte attachment and dendricity. J Cell Sci. 1994; 107:2739–2748.
Article
29. Choi W, Wolber R, Gerwat W, Mann T, Batzer J, Smuda C, et al. The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin. J Cell Sci. 2010; 123:3102–3111.
Article
30. Yamaguchi Y, Morita A, Maeda A, Hearing VJ. Regulation of skin pigmentation and thickness by Dickkopf 1 (DKK1). J Investig Dermatol Symp Proc. 2009; 14:73–75.
Article
31. Cardinali G, Ceccarelli S, Kovacs D, Aspite N, Lotti LV, Torrisi MR, et al. Keratinocyte growth factor promotes melanosome transfer to keratinocytes. J Invest Dermatol. 2005; 125:1190–1199.
Article
32. Cardinali G, Bolasco G, Aspite N, Lucania G, Lotti LV, Torrisi MR, et al. Melanosome transfer promoted by keratinocyte growth factor in light and dark skin-derived keratinocytes. J Invest Dermatol. 2008; 128:558–567.
Article
33. Kovacs D, Cardinali G, Aspite N, Cota C, Luzi F, Bellei B, et al. Role of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo. Br J Dermatol. 2010; 163:1020–1027.
Article
34. Chen N, Hu Y, Li WH, Eisinger M, Seiberg M, Lin CB. The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines. Exp Dermatol. 2010; 19:865–872.
Article
35. Snell RS. The pigmentary changes occurring in the breast skin during pregnancy and following estrogen treatment. J Invest Dermatol. 1964; 43:181–186.
Article
36. Wilson MJ, Spaziani E. The melanogenic response to testosterone in scrotal epidermis: effects on tyrosinase activity and protein synthesis. Acta Endocrinol (Copenh). 1976; 81:435–448.
Article
37. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol. 2007; 29:3–14.
Article
38. Si J, Lee S, Park JM, Sung J, Ko G. Genetic associations and shared environmental effects on the skin microbiome of Korean twins. BMC Genomics. 2015; 16:992–1002.
Article
39. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991; 24:1–26.
Article
40. Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis. J Immunol. 2010; 184:5263–5270.
Article
41. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006; 203:2271–2279.
Article
42. Gläser R, Navid F, Schuller W, Jantschitsch C, Harder J, Schröder JM, et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol. 2009; 123:1117–1123.
Article
43. Elias PM, Menon G, Wetzel BK, Williams J. Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humans. Am J Hum Biol. 2010; 22:526–537.
Article
44. Jung SE, Kang HY, Lee ES, Kim YC. Changes of epidermal thickness in vitiligo. Am J Dermatopathol. 2015; 37:289–292.
Article
45. Ganju P, Nagpal S, Mohammed MH, Nishal Kumar P, Pandey R, Natarajan VT, et al. Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects. Sci Rep. 2016; 6:18761.
Article
46. Maresca V, Flori E, Camera E, Bellei B, Aspite N, Ludovici M, et al. Linking αMSH with PPARγ in B16-F10 melanoma. Pigment Cell Melanoma Res. 2013; 26:113–127.
Article
47. Buscà R, Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 2000; 13:60–69.
Article
48. Herraiz C, Journé F, Abdel-Malek Z, Ghanem G, Jiménez-Cervantes C, García-Borrón JC. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol Endocrinol. 2011; 25:138–156.
Article
49. Bellei B, Pitisci A, Izzo E, Picardo M. Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway. PLoS One. 2012; 7:e33021.
Article
50. Kang HY, Chung E, Lee M, Cho Y, Kang WH. Expression and function of peroxisome proliferator-activated receptors in human melanocytes. Br J Dermatol. 2004; 150:462–468.
Article
51. Flori E, Mastrofrancesco A, Kovacs D, Ramot Y, Briganti S, Bellei B, et al. 2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-γ activation. Pigment Cell Melanoma Res. 2011; 24:618–630.
Article
52. Aoki H, Moro O, Tagami H, Kishimoto J. Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics. Br J Dermatol. 2007; 156:1214–1223.
Article
53. Lin CB, Hu Y, Rossetti D, Chen N, David C, Slominski A, et al. Immuno-histochemical evaluation of solar lentigines: The association of KGF/KGFR and other factors with lesion development. J Dermatol Sci. 2010; 59:91–97.
Article
54. Salducci M, André N, Guéré C, Martin M, Fitoussi R, Vié K, et al. Factors secreted by irradiated aged fibroblasts induce solar lentigo in pigmented reconstructed epidermis. Pigment Cell Melanoma Res. 2014; 27:502–504.
Article
55. Duval C, Cohen C, Chagnoleau C, Flouret V, Bourreau E, Bernerd F. Key regulatory role of dermal fibroblasts in pigmentation as demonstrated using a reconstructed skin model: impact of photo-aging. PLoS One. 2014; 9:e114182.
Article
56. Hasegawa K, Fujiwara R, Sato K, Shin J, Kim SJ, Kim M, et al. Possible involvement of keratinocyte growth factor in the persistence of hyperpigmentation in both human facial solar lentigines and melasma. Ann Dermatol. 2015; 27:626–629.
Article
57. Iriyama S, Ono T, Aoki H, Amano S. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction. J Dermatol Sci. 2011; 64:223–228.
Article
58. Miot LD, Miot HA, Polettini J, Silva MG, Marques ME. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study. Am J Dermatopathol. 2010; 32:676–682.
Article
59. Kang HY, Hwang JS, Lee JY, Ahn JH, Kim JY, Lee ES, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006; 154:1094–1099.
Article
60. Lee DJ, Park KC, Ortonne JP, Kang HY. Pendulous melanocytes: a characteristic feature of melasma and how it may occur. Br J Dermatol. 2012; 166:684–686.
Article
61. Torres-Álvarez B, Mesa-Garza IG, Castanedo-Cázares JP, Fuentes-Ahumada C, Oros-Ovalle C, Navarrete-Solis J, et al. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane. Am J Dermatopathol. 2011; 33:291–295.
Article
62. Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007; 46:111–116.
Article
63. Kim M, Han JH, Kim JH, Park TJ, Kang HY. Secreted frizzled-related protein 2 (sFRP2) functions as a melanogenic stimulator; the role of sFRP2 in UV-induced hyperpigmentary disorders. J Invest Dermatol. 2016; 136:236–244.
Article
64. Shishido E, Kadono S, Manaka I, Kawashima M, Imokawa G. The mechanism of epidermal hyperpigmentation in dermatofibroma is associated with stem cell factor and hepatocyte growth factor expression. J Invest Dermatol. 2001; 117:627–633.
Article
65. Okazaki M, Yoshimura K, Suzuki Y, Uchida G, Kitano Y, Harii K, et al. The mechanism of epidermal hyperpigmentation in café-au-lait macules of neurofibromatosis type 1 (von Recklinghausen's disease) may be associated with dermal fibroblast-derived stem cell factor and hepatocyte growth factor. Br J Dermatol. 2003; 148:689–697.
Article
66. Cardinali G, Kovacs D, Giglio MD, Cota C, Aspite N, Amantea A, et al. A kindred with familial progressive hyperpigmentation-like disorder: implication of fibroblast-derived growth factors in pigmentation. Eur J Dermatol. 2009; 19:469–473.
Article
67. Lan CC, Wu CS, Cheng CM, Yu CL, Chen GS, Yu HS. Pigmentation in basal cell carcinoma involves enhanced endothelin-1 expression. Exp Dermatol. 2005; 14:528–534.
Article
68. Teraki E, Tajima S, Manaka I, Kawashima M, Miyagishi M, Imokawa G. Role of endothelin-1 in hyperpigmentation in seborrhoeic keratosis. Br J Dermatol. 1996; 135:918–923.
Article
69. Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al. Vitiligo. Nat Rev Dis Primers. 2015; 1:15011.
Article
70. XXII International Pigment Cell Conference (IPCC). "Bringing Colors to Life: Advances in Pigment Cell Research and Translation into Clinical Practice" Organised by the Asian Society for Pigment Cell Research (ASPCR), in partnership with the Dermatological Society of Singapore (DSS). Pigment Cell Melanoma Res. 2014; 27:849–1001.
71. Bellei B, Pitisci A, Ottaviani M, Ludovici M, Cota C, Luzi F, et al. Vitiligo: a possible model of degenerative diseases. PLoS One. 2013; 8:e59782.
Article
72. Kitamura R, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T, et al. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol. 2004; 202:463–475.
Article
73. Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, et al. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol. 2009; 24:849–857.
74. Lee AY, Kim NH, Choi WI, Youm YH. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol. 2005; 124:976–983.
Article
75. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res. 2002; 15:87–92.
Article
76. Wagner RY, Luciani F, Cario-André M, Rubod A, Petit V, Benzekri L, et al. Altered e-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo. J Invest Dermatol. 2015; 135:1810–1819.
Article
77. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion. Br J Dermatol. 1997; 137:171–178.
Article
78. Ricard AS, Pain C, Daubos A, Ezzedine K, Lamrissi-Garcia I, Bibeyran A, et al. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol. 2012; 21:411–416.
Article
79. Oh SH, Kim JY, Kim MR, Do JE, Shin JY, Hann SK. DKK1 is highly expressed in the dermis of vitiligo lesion: is there association between DKK1 and vitiligo. J Dermatol Sci. 2012; 66:163–165.
Article
80. Purpura V, Persechino F, Belleudi F, Scrofani C, Raffa S, Persechino S, et al. Decreased expression of KGF/FGF7 and its receptor in pathological hypopigmentation. J Cell Mol Med. 2014; 18:2553–2557.
Article
81. Nishimura EK. Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res. 2011; 24:401–410.
Article
82. Ueno M, Aoto T, Mohri Y, Yokozeki H, Nishimura EK. Coupling of the radiosensitivity of melanocyte stem cells to their dormancy during the hair cycle. Pigment Cell Melanoma Res. 2014; 27:540–551.
Article
83. Goldstein NB, Koster MI, Hoaglin LG, Spoelstra NS, Kechris KJ, Robinson SE, et al. Narrow band ultraviolet B treatment for human vitiligo is associated with proliferation, migration, and differentiation of melanocyte precursors. J Invest Dermatol. 2015; 135:2068–2076.
Article
84. Taïeb A, Picardo M. VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007; 20:27–35.
Article
85. Esmat SM, El-Tawdy AM, Hafez GA, Zeid OA, Abdel Halim DM, Saleh MA, et al. Acral lesions of vitiligo: why are they resistant to photochemotherapy? J Eur Acad Dermatol Venereol. 2012; 26:1097–1104.
Article
86. Li L, Fukunaga-Kalabis M, Yu H, Xu X, Kong J, Lee JT, et al. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci. 2010; 123:853–860.
Article
87. Okamoto N, Aoto T, Uhara H, Yamazaki S, Akutsu H, Umezawa A, et al. A melanocyte--melanoma precursor niche in sweat glands of volar skin. Pigment Cell Melanoma Res. 2014; 27:1039–1050.
Article
88. Jang YH, Kim SL, Lee JS, Kwon KY, Lee SJ, Kim do W, et al. Possible existence of melanocytes or melanoblasts in human sebaceous glands. Ann Dermatol. 2014; 26:469–473.
Article